Yuichi Honma

Kitakyushu, 8078555, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Dynamic Nutritional Decline During the Diagnostic-to-Treatment Interval Is Associated with Treatment Resilience and Survival in Unresectable Pancreatic Ductal Adenocarcinoma.

Dynamic Nutritional Decline During the Diagnostic-to-Treatment Interval Is Associated with Treatment Resilience and Survival in Unresectable Pancreatic Ductal Adenocarcinoma.

Journal: Nutrients

Published: May 30, 2026

Pretreatment geriatric nutritional risk index is associated with impaired treatment continuity and supportive care-relevant outcomes in unresectable pancreatic ductal adenocarcinoma.

Pretreatment geriatric nutritional risk index is associated with impaired treatment continuity and supportive care-relevant outcomes in unresectable pancreatic ductal adenocarcinoma.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: April 27, 2026

A Stomach-Positioned Splinting Tube Technique for Maintaining a Straightened Gastric Axis During Endoscopic Retrograde Cholangiopancreatography in Severe Esophageal Hiatal Hernia.

A Stomach-Positioned Splinting Tube Technique for Maintaining a Straightened Gastric Axis During Endoscopic Retrograde Cholangiopancreatography in Severe Esophageal Hiatal Hernia.

Journal: ACG case reports journal

Published: April 09, 2026

Determinants of eligibility for second-line chemotherapy following gemcitabine plus nab-paclitaxel therapy in patients with unresectable pancreatic cancer: a retrospective study.

Determinants of eligibility for second-line chemotherapy following gemcitabine plus nab-paclitaxel therapy in patients with unresectable pancreatic cancer: a retrospective study.

Journal: BMC gastroenterology

Published: April 01, 2026

Cholecystocolonic Fistula Associated With Advanced Mirizzi Syndrome Causing Chronic Diarrhea: Successful Treatment Using Cholangioscopy-Guided Lithotripsy and Surgery.

Cholecystocolonic Fistula Associated With Advanced Mirizzi Syndrome Causing Chronic Diarrhea: Successful Treatment Using Cholangioscopy-Guided Lithotripsy and Surgery.

Journal: Case reports in gastrointestinal medicine

Published: January 15, 2026

Post-EUS-FNB Mediastinal Abscess in a Lung Cancer Patient With Mediastinal Lymph Node Metastasis: A Case Report and Literature Review.

Post-EUS-FNB Mediastinal Abscess in a Lung Cancer Patient With Mediastinal Lymph Node Metastasis: A Case Report and Literature Review.

Journal: Journal of UOEH

Published: November 30, 2025

Poorly differentiated clusters surpass tumor budding as novel prognostic factors in pancreatic cancer, especially in cases treated with neoadjuvant chemotherapy.

Poorly differentiated clusters surpass tumor budding as novel prognostic factors in pancreatic cancer, especially in cases treated with neoadjuvant chemotherapy.

Journal: BMC gastroenterology

Published: November 28, 2025

EUS-TD With Multiple Plastic Stents for Postoperative Pancreatic Fistula: A Retrospective Evaluation of Early Postsurgery Management.

EUS-TD With Multiple Plastic Stents for Postoperative Pancreatic Fistula: A Retrospective Evaluation of Early Postsurgery Management.

Journal: Surgical laparoscopy, endoscopy & percutaneous techniques

Published: August 11, 2025

Double catheter technique for difficult biliary cannulation: A novel application of the two-devices-in-one-channel method.

Double catheter technique for difficult biliary cannulation: A novel application of the two-devices-in-one-channel method.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: July 01, 2025

Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study.

Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 27, 2025

A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination therapy in hepatocellular carcinoma.

A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination therapy in hepatocellular carcinoma.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 18, 2025

Usefulness of the Early Increase of Peripheral Blood Lymphocyte Count in Predicting Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma Treated with Durvalumab Plus Tremelimumab.

Usefulness of the Early Increase of Peripheral Blood Lymphocyte Count in Predicting Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma Treated with Durvalumab Plus Tremelimumab.

Journal: Cancers

Published: March 03, 2025

Showing 1-12 of 70

Last Updated: 09/26/2026